First nine months 2020 Results Press Release

Download our press release published on 5 November to find out the financial results for the first nine months of 2020.


No votes yet
 
Related
ROVI reports operating revenue growth of 12% and net profit growth of 53%
Today, Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specialising and engaging in the...
5 min
24/11/2020
Recruitment of two doctors for the R&D area under the Torres Quevedo Programme 2020
ROVI is a company committed to innovation, allowing it to safeguard its portfolio composed of over 500 patent dossiers, 408 of which have...
1 min
30/10/2020